AT-7519
| CAS No. | 844442-38-2 |
|---|---|
| MDL No. | MFCD13184820 |
| MF | C16H17Cl2N5O2 |
| MW | 382.20 |
| InChI Key | OVPNQJVDAFNBDN-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)pyrazole-3-carboxamide is a pyrazole derivative in which the 4-amino group of 1H-pyrazole-3-carboxylic acid is acylated with a 2,6-dichlorobenzoyl group, and the carboxylic acid is converted into a carboxamide via condensation with the primary amino group of 4-aminopiperidine. It functions as a cyclin-dependent kinase inhibitor and antineoplastic agent. It is a secondary carboxamide, a pyrazole, a dichlorobenzene, and a piperidine.
| CAS No. | 844442-38-2 |
|---|---|
| Product Name | AT-7519 |
Biological Targets
CDK1·CDK4·CDK2·CDK5·CDK6·
Associated Conditions
multiple myeloma·Mantle cell lymphoma·neoplasm·lymphoma·chronic lymphocytic leukemia
* The information provided here is compiled from public sources and is for reference only.
